An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...
1don MSN
Pittsburgh-area lawmakers and organizations aim to raise awareness about prostate cancer risks
September marks the beginning of National Prostate Cancer Awareness Month in the United States.
Reginald Tucker-Seeley, MA, ScM, ScD, concludes the program with advice for caregivers and patients with prostate cancer to maximize the benefit of treatment. This is a synopsis of an Educated Patient ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men. The relationship between low handgrip strength (HGS) and prostate ...
According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results